NovoCure NVCR reported its Q2 earnings results on Thursday, July 28, 2022 at 06:00 AM.
Here's what investors need to know about the announcement.
Earnings
NovoCure missed estimated earnings by 53.33%, reporting an EPS of $-0.23 versus an estimate of $-0.15.
Revenue was up $7.35 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.14 which was followed by a 0.78% drop in the share price the next day.
Here's a look at NovoCure's past performance:
Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
---|---|---|---|---|
EPS Estimate | -0.18 | -0.10 | -0.07 | 0.01 |
EPS Actual | -0.04 | -0.25 | -0.13 | -0.14 |
Revenue Estimate | 134.08M | 135.42M | 141.76M | 141.89M |
Revenue Actual | 137.55M | 133.21M | 133.61M | 133.52M |
To track all earnings releases for NovoCure visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.